Opko Health Inc. Stock Nyse
Equities
US68375N1037
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
|
05-07 | Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M | MT |
05-07 | Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024 | CI |
Sales 2024 * | 715M 979M | Sales 2025 * | 754M 1.03B | Capitalization | 899M 1.23B |
---|---|---|---|---|---|
Net income 2024 * | -265M -363M | Net income 2025 * | -195M -267M | EV / Sales 2024 * | 1.26 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
-3.46
x | P/E ratio 2025 * |
-4.78
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.64% |
Latest transcript on Opko Health Inc.
Managers | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Adam Logal
DFI | Director of Finance/CFO | 46 | 07-02-28 |
Elias Zerhouni
PSD | President | 72 | 22-05-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Roger Medel
BRD | Director/Board Member | 77 | 20-12-17 |
Director/Board Member | 68 | 07-12-31 |
1st Jan change | Capi. | |
---|---|---|
-18.17% | 8.53B | |
+65.89% | 4.26B | |
+6.56% | 2.71B | |
-1.93% | 2.63B | |
-57.14% | 1.72B | |
-19.16% | 1.67B | |
-20.01% | 1.45B | |
+15.38% | 1.19B | |
-50.40% | 1.01B |